Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Assessing the safety of biologic agents in patients with rheumatoid arthritis.
Dermatoglyphic features in patients with multiple sclerosis.
Introduction: occupational therapy practice and research with persons with multiple sclerosis.
Strengths and limitations of microarray-based phenotype prediction: Lessons learned from the IMPROVER Diagnostic Signature Challenge.
Long-term endurance exercise improves aerobic capacity in patients with relapsing-remitting Multiple Sclerosis: Impact of baseline fatigue.
Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
Transient hyperCKemia in the setting of neuromyelitis optica (NMO).
Functional outcomes associated with expiratory muscle strength training: Narrative review.
Human pluripotent stem cell-derived neural constructs for predicting neural toxicity.
Treatment of pediatric chronic inflammatory demyelinating polyneuropathy: Challenges, controversies and questions.
Fingolimod: a review of its mode of action in the context of its efficacy and safety profile in relapsing forms of multiple sclerosis.
Confronting Patients About Insufficient Effort: The Impact on Subsequent Symptom Validity and Memory Performance.
The CD27 and CD70 Costimulatory Pathway Inhibits Effector Function of T Helper 17 Cells and Attenuates Associated Autoimmunity.
Monitoring of active human herpes virus 6 infection in Iranian patients with different subtypes of multiple sclerosis.
Pragmatic exercise intervention in people with mild to moderate multiple sclerosis: A randomised controlled feasibility study.
Oculopalatal tremor in multiple sclerosis with spontaneous resolution.
Alteration of prolyl oligopeptidase and activated alpha-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome.
A qualitative review of the neurophysiological underpinnings of fatigue in multiple sclerosis.
The use of interferon Beta and glatiramer acetate in multiple sclerosis.
Is It Too Early to Predict the Failure of Natalizumab in NMO?-Reply.
Mouse CD11b+Gr-1+ Myeloid Cells Can Promote Th17 Cell Differentiation and Experimental Autoimmune Encephalomyelitis.
Intrathecal baclofen in multiple sclerosis.
IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.
Translation and Cultural Adaptation of the Multidimensional Scale of Perceived Social Support for Greece.
Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review.

Pages